Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.
Clinical trial NCT00611715 · TERMINATED
Trial details
- NCT number
- NCT00611715
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2008-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.